In vitro pharmacology group is experienced at developing cell based assays to assist preclinical drug discovery. Fidelta has developed disease relevant assays in human primary cells and tissues which can be used for:

  • Target validation
  • Compound profiling and mode of action studies
  • Biomarker research

We focus on:

  • Inflammation
  • Respiratory diseases
  • Gastrointestinal diseases
  • Bone and joint diseases
  • Autoimmune diseases
  • Fibrosis
  • Oncology
  • Immuno-Oncology

Assay specifics:

  • Various triggers
  • Readouts translatable to in vivo models and clinics
  • Inflammatory mediator production
  • Cell surface and intracellular markers expression
  • Cell proliferation

Tailor-made cell-based assays according to customer’s needs can be developed. For more information on our capabilities please contact us.